2018
DOI: 10.1016/j.ekir.2018.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation

Abstract: IntroductionApolipoprotein CII amyloidosis (AApoCII) is a rare form of amyloidosis. Here, we report a novel mutation associated with AApoCII amyloidosis in 5 patients and describe their clinical, renal biopsy, and mass spectrometry findings.MethodsFive patients with renal AApoCII p.Lys41Thr amyloidosis were identified from our amyloid mass spectrometry cohort. Clinical features, kidney biopsy, and mass spectrometry findings were analyzed in this rare type of amyloidosis.ResultsThe patients were older adults (m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
17
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 36 publications
0
17
0
Order By: Relevance
“…It is also possible to detect novel amino acid substitutions in the amyloid proteins using a sequence tagging-based bioinformatics approach. 49,50 This strategy further extends the discovery capability of MS. 31,[51][52][53][54][55] Despite the power of novel bioinformatics approaches, it is not possible to detect all amino acid substitutions. For example, substitutions in short tryptic peptides are usually not detectable.…”
Section: Discussionmentioning
confidence: 92%
“…It is also possible to detect novel amino acid substitutions in the amyloid proteins using a sequence tagging-based bioinformatics approach. 49,50 This strategy further extends the discovery capability of MS. 31,[51][52][53][54][55] Despite the power of novel bioinformatics approaches, it is not possible to detect all amino acid substitutions. For example, substitutions in short tryptic peptides are usually not detectable.…”
Section: Discussionmentioning
confidence: 92%
“…Therefore, a proportion of cases of AFib amyloidosis currently are diagnosed on the basis of amyloid with typical renal morphology in the absence of specific IHC staining, in conjunction with the presence of a pathogenic FGA mutation on direct DNA sequencing, with the diagnosis sometimes further supported by a family history of the disease and/or a typical disease course 13 . More recently, proteomic analysis of amyloidotic tissue, a technique pioneered by the Mayo Clinic,19, 20, 21, 22, 23 is now used in certain specialist amyloidosis centers to identify the amyloid fibril protein, complementing the diagnostic value of histology, IHC, and related techniques 24, 25, 26, 27…”
mentioning
confidence: 99%
“…We used NAMD ( 41 ) and the CHARMM27 with the CMAP ( 42 ) force field for Generalized Born implicit solvent molecular dynamics (isMD) simulations using previously optimized conditions ( 43 ) that included the following: 1) an interaction cutoff of 15Å; 2) strength tapering (switching) starting at 12Å; 3) a 1fs simulation time step with conformations recorded every 2ps; 4) an initial conformation that was energy minimized for 20,000 steps; and 5) heating to 300K over 300ps via a Langevin thermostat. From each of the 12 conditions (two initial conformations, two alleles, and three ligand states), 100ns of simulation trajectory was generated and the final 70ns analyzed.…”
Section: Methodsmentioning
confidence: 99%